Drug stops multiple sclerosis - but sufferers can't get it!
News-Medical-Net Tue, 29 Nov 2005 3:30 PM PST
Cris Kerr highlights Naltrexone in her latest issue of 'Case Health - Health Success Stories'.

Dendritic cells offer new therapeutic target for drugs to treat MS and other autoimmune disease EurekAlert! Tue, 29 Nov 2005 2:07 PM PST Scientists at the Johns Hopkins Kimmel Cancer Center have found that a gene pathway linked to a deadly form of leukemia may provide a new way to treat autoimmune diseases, including multiple sclerosis. Their tests in cell cultures and mice suggest that blocking the pathway by interfering with a blood cell growth gene, known as FLT3, targets an immune system cell often ignored in favor of T-cell

Dendritic Cells Offer New Therapeutic Target for Drugs to Treat MS Newswise Tue, 29 Nov 2005 2:25 PM PST Scientists have found that a gene pathway linked to a deadly form of leukemia may provide a new way to treat autoimmune diseases, including multiple sclerosis. Their tests suggest that blocking the pathway by interfering with a blood cell growth gene targets an immune system cell often ignored in favor of T-cell targets in standard therapies.

Yale School of Medicine Focuses Top Scientists on Neurodegenerative Diseases Yale University Tue, 29 Nov 2005 12:36 PM PST New Haven, Conn. — Yale School of Medicine, accelerating the pace of research on neurodegenerative diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis, today announced the launch of an interdepartmental program in Cellular Neuroscience, Neurodegeneration and Repair (CNNR).

PS Double Blind Trials For Memory RedNova Wed, 30 Nov 2005 5:49 AM PST By Anonymous Trials Against Age-Associated Memory Impairment 1. Crook and collaborators, USA and Italy.17 T. H. Crook and five co-researchers did this multicenter U.S. trial with 149 patients who fit the criteria for age-associated memory impairment (AAMI).

30 November 2005 PharmiWeb Wed, 30 Nov 2005 4:55 AM PST Resources | Features | HIV doctors underestimate patients’... Patients who could benefit from injectable therapies are a lot less needle-phobic than doctors assume, according to research conducted by pharmacist and behavioural scientist Professor Robert Horne.

Dilemma on prescriptions The Scotsman: Health Tue, 29 Nov 2005 4:30 PM PST THE Labour-Lib Dem coalition has came under pressure from its own backbenchers to publish its alternative to Socialist plans to scrap all prescription charges.

Honors & Awards UCSF Today Wed, 30 Nov 2005 0:36 AM PST Leslie Z. Benet , professor of biopharmaceutical sciences and pharmaceutical chemistry, UCSF School of Pharmacy: Received the doctor honoris causa from the University of Athens on Oct. 7, 2005. This is the highest honorary title awarded by the university.